The Neurocritical Care Society of India (NCSI) and the Indian Society of Neuroanaesthesiology and Critical Care (ISNACC) Joint Position Statement and Advisory on the Practice of Neurocritical Care during the COVID-19 Pandemic

Ponniah Vanamoorthy; Gyaninder P. Singh; Prasanna U. Bidkar; Ranadhir Mitra; Kamath Sriganesh; Siddharth Chavali; Radhakrishnan Muthuchellapan; Venkatesh H. Keshavan; Saurabh Anand; Keshav Goyal; Rahul Yadav; Girija P. Rath; Shashi Srivastava

doi:10.1055/s-0040-1714648

Journal of Neuroanaesthesiology and Critical Care, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2020; 7(03): 128-139
DOI: 10.1055/s-0040-1714648

Review Article

The Neurocritical Care Society of India (NCSI) and the Indian Society of Neuroanaesthesiology and Critical Care (ISNACC) Joint Position Statement and Advisory on the Practice of Neurocritical Care during the COVID-19 Pandemic

Ponniah Vanamoorthy

¹Department of Neuroanaesthesiology and Neurocritical Care, Institute of Neurosciences and Spinal Disorders, MGM Healthcare, Chennai, Tamil Nadu, India

,

Gyaninder P. Singh

²Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India

,

Prasanna U. Bidkar

³Division of Neuroanaesthesiology, Department of Anesthesiology and Critical care, Jawaharlal Institute of Post Graduate Medical Education and Research, Puducherry, India

,

Ranadhir Mitra

⁴Department of Neuroanesthesia and Neurocritical Care, Care Hospital, Bhubaneswar, Odisha, India

,

Kamath Sriganesh

⁵Department of Neuroanaesthesiology and Neurocritical Care, National Institute of Mental Health and Neuro-Sciences, Bengaluru, Karnataka, India

,

Siddharth Chavali

⁶Department of Neurosciences, Aditya Birla Memorial Hospital, Pune, Maharashtra, India

,

Radhakrishnan Muthuchellapan

⁵Department of Neuroanaesthesiology and Neurocritical Care, National Institute of Mental Health and Neuro-Sciences, Bengaluru, Karnataka, India

,

Venkatesh H. Keshavan

⁷Department of Neuroanaesthesiology and Neurocritical Care, Apollo Hospitals, Bengaluru, Karnataka, India

,

Saurabh Anand

⁸Department of Neuroanaesthesia and Neurocritical Care, Artemis Hospital, Gurugram, Haryana, India

,

Keshav Goyal

²Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India

,

Rahul Yadav

⁹Department of Anaesthesiology and Critical Care, INHS Asvini, Mumbai, Maharashtra, India

,

Girija P. Rath

²Department of Neuroanaesthesiology and Critical Care, All India Institute of Medical Sciences, New Delhi, India

,

Shashi Srivastava

¹⁰Department of Anesthesiology and Critical Care, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

› Institutsangaben

Abstract

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2) has rapidly spread across the world including India. Management of patients complicated with neurological illness requiring neurocritical care is challenging during this time. Patients with neurological disease may develop COVID-19 infection or there could be independent neurological manifestations of COVID-19. Critically ill neurological patients are more vulnerable to contracting SARS-CoV-2 infection. Also, neurological patients with comorbidities and multisystem involvement are at increased risk of adverse outcomes. Though SARS-CoV-2 predominantly affects the pulmonary system, it can complicate the assessment and management of neurological patients. With increasing COVID-19 numbers, the hospitalizations of both non-COVID and COVID-19 neurological patients will bring significant strain on the hospital and neurocritical care facilities. Streamlining work pattern, understanding the pathophysiology of COVID-19 and its impact on neurological function, establishing general and specific neurocritical care management strategies, ensuring protection and well-being of health care providers, and implementing effective infection control policies are key elements of efficient neurocritical care management during this pandemic. This joint position statement and advisory on the practice of neurocritical care during the COVID-19 pandemic by the Neurocritical Care Society of India and the Indian Society of Neuroanaesthesiology and Critical Care has been developed to guide clinicians providing care to the critically ill neurological patients in the neurocritical care unit during the current pandemic. As the situation from this novel disease is rapidly evolving, readers must constantly update themselves with newly emerging evidence to provide the best possible care to the critically ill neurological patients.

Keywords

COVID-19 pandemic - SARS-CoV-2 - neurological manifestations - critically ill neurological patients - neurocritical care management

Volltext

Referenzen

References
1 Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypoxemia is baffling to physicians. Am J Respir Crit Care Med 2020;
2 Xiao AT, Tong YX, Zhang S. False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: rather than recurrence. J Med Virol 2020.
3 Goh KJ, Wong J, Tien JC. et al. Preparing your intensive care unit for the COVID-19 pandemic: practical considerations and strategies. Crit Care 2020; 24 (01) 215
4 Martland AM, Huffines M, Henry K. Surge priority planning COVID-19: critical care staffing and nursing considerations. CHEST 2020. Available at: http://www.chestnet.org/Guidelines-and-Resources/Resources/Surge-Priority-Planning-COVID-19-Critical-Care-Staffing-and-Nursing-Considerations. Accessed June 10, 2020
5 New WHO tools launched to help hospitals manage surge in COVID-19 patients. April 8, 2020. Available at: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/4/new-who-tools-launched-to-help-hospitals-manage-surge-in-covid-19-patients. Accessed June 10, 2020
6 List N. Disinfectants for Use Against SARS-CoV-2 (COVID-19). 2020. Available at: https://www.epa.gov/pesticide-registration/list-n-disinfectants-use-against-sars-cov-2. Accessed June 15, 2020
7 COVID-19. Guidelines on disinfection of common public places including offices. 2020. Available at: https://www.mohfw.gov.in/pdf/Guidelinesondisinfectionofcommonpublicplacesincludingoffices.pdf. Accessed June 15, 2020
8 Instructions to all major and minor ports for dealing with novel coronavirus (COVID-19) pandemic. Cleaning agents and disinfectants. 2020. Available at: https://www.mohfw.gov.in/pdf/DGSOrder04of2020.pdf. Accessed June 15, 2020
9 Coronavirus Disease. 2019 (COVID-19): Standard Operating Procedure (SOP) for transporting a suspectirmed case of COVID-19. 2020. Available at: https://www.mohfw.gov.in/pdf/StandardOperatingProcedureSOPfortransportingasuspectorconfirmedcaseofCOVID19.pdf. Accessed June 10, 2020
10 Guidelines for disinfection of quarantine facility (for COVID-19). 2020. Available at: https://ncdc.gov.in/WriteReadData/l892s/89168637271584172711.pdf. Accessed June 15, 2020
11 Novel Coronavirus Disease. 2019 (COVID-19): Guidelines on rational use of Personal Protective Equipment. 2020. Available at: https://www.mohfw.gov.in/pdf/Guideli0nesonrationaluseofPersonalProtectiveEquipment.pdf. Accessed June 10, 2020
12 Novel Coronavirus Disease. 2019 (COVID-19): Additional guidelines on rational use of Personal Protective Equipment (setting approach for Health functionaries working in non-COVID areas). 2020. Available at: https://www.mohfw.gov.in/pdf/AdditionalguidelinesonrationaluseofPersonalProtectiveEquipmentsettingapproachforHealthfunctionariesworkinginnonCOVIDareas.pdf. Accessed June 10, 2020
13 National guidelines for infection prevention and control in healthcare facilities. 2020. Available at: https://www.mohfw.gov.in/pdf/National%20Guidelines%20for%20IPC%20in%20HCF%20-%20final%281%29.pdf. Accessed June 10, 2020
14 Using Personal Protective Equipment (PPE). 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/using-ppe.html. Accessed June 10, 2020
15 Steps to put on personal protective equipment (PPE). 2020. Available at: https://www.who.int/csr/disease/ebola/put_on_ppequipment.pdf. Accessed June 10, 2020
16 El-Boghdadly K, Wong DJN, Owen R. et al. Risks to healthcare workers following tracheal intubation of patients with COVID-19: a prospective international multicentre cohort study. Anaesthesia 2020:
17 World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: Interim guidance. March 13, 2020. Available at: https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2. Accessed June 16, 2020
18 Alhazzani W, Møller MH, Arabi YM. et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 46 (05) 854-887
19 Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;
20 NIH-Coronavirus Disease. 2019 (COVID-19) Treatment Guideline. 2020. Available at: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf. Accessed June 16, 2020
21 van den Boom W, Hoy M, Sankaran J. et al. The search for optimal oxygen saturation targets in critically ill patients: observational data from large ICU databases. Chest 2020; 157 (03) 566-573
22 Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020: 10.1001/jamainternmed.2020.0994
23 Cornejo RA, Díaz JC, Tobar EA. et al. Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2013; 188 (04) 440-448
24 Munshi L, Del Sorbo L, Adhikari NKJ. et al. Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis. Ann Am Thorac Soc 2017; 14 (Suppl. 04) S280-S288
25 Bloomfield R, Noble DW, Sudlow A. Prone position for acute respiratory failure in adults. Cochrane Database Syst Rev 2015; (11) CD008095
26 Mora-Arteaga JA, Bernal-Ramírez OJ, Rodríguez SJ. The effects of prone position ventilation in patients with acute respiratory distress syndrome. A systematic review and meta-analysis. Med Intensiva 2015; 39 (06) 359-372
27 Lee JM, Bae W, Lee YJ, Cho YJ. The efficacy and safety of prone positional ventilation in acute respiratory distress syndrome: updated study-level meta-analysis of 11 randomized controlled trials. Crit Care Med 2014; 42 (05) 1252-1262
28 Roth C, Ferbert A, Deinsberger W. et al. Does prone positioning increase intracranial pressure? A retrospective analysis of patients with acute brain injury and acute respiratory failure. Neurocrit Care 2014; 21 (02) 186-191
29 Nekludov M, Bellander BM, Mure M. Oxygenation and cerebral perfusion pressure improved in the prone position. Acta Anaesthesiol Scand 2006; 50 (08) 932-936
30 Yang X, Yu Y, Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8 (05) 475-481
31 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061-1069
32 Zhou F, Yu T, Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395 (10229) 1054-1062
33 Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46 (05) 846-848
34 Guan WJ, Ni ZY, Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
35 Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;e201127. Doi: 10.1001/jamaneurol.2020.1127
36 Oxley TJ, Mocco J, Majidi S. et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020; 382 (20) e60
37 Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus 2020; 12 (03) e7352
38 Hepburn M, Mullaguri N, George P, et al. Acute symptomatic seizures in critically ill patients with COVID-19: is there an association? Neurocrit Care 2020: 10.1007/s12028-020-01006-1
39 Louis S, Dhawan A, Newey C, et al. Continuous electroencephalography (cEEG) characteristics and acute symptomatic seizures in COVID-19 patients. medRxiv; 2020: 10.1101/2020.05.26.20114033
40 Li Y, Wang M, Zhou Y. et al. Acute cerebrovascular disease following covid-19: a single center, retrospective, observational study. Lancet 2020;
41 Yaghi S, Ishida K, Torres J. et al. SARS-CoV-2 and stroke in a New York healthcare system. Stroke 2020; 51 (07) 2002-2011
42 Varga Z, Flammer AJ, Steiger P. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395 (10234) 1417-1418
43 Michot JM, Albiges L, Chaput N. et al. Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. Ann Oncol 2020; 31 (07) 961-964
44 Monteleone G, Sarzi-Puttini PC, Ardizzone S. Preventing COVID-19-induced pneumonia with anticytokine therapy. Lancet Rheumatol 2020; 2 (05) e255-e256
45 Castiglione V, Chiriacò M, Emdin M, Taddei S, Vergaro G. Statin therapy in COVID-19 infection. Eur Heart J Cardiovasc Pharmacother 2020; 42
46 Dashti-Khavidaki S, Khalili H. Considerations for statin therapy in patients with COVID-19. Pharmacotherapy 2020; 40 (05) 484-486
47 Virani SS. Is There a Role For Statin Therapy in Acute Viral Infections? Cardiology Magazine; 2020. Available at: https://www.acc.org/latest-in-cardiology/articles/2020/03/18/15/09/is-there-a-role-for-statin-therapy-in-acute-viral-infections-covid-19. Accessed July 9, 2020
48 Zhang W, Zhao Y, Zhang F. et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol 2020; 214: 108393
49 Stebbing J, Phelan A, Griffin I. et al. COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis 2020; 20 (04) 400-402
50 Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135 (23) 2033-2040
51 Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic. Stroke 2020; 51 (06) 1891-1895
52 Neurointervention Committee of the Chinese Medical Doctor Association. Recommendation of experts on prevention and control of new coronavirus infection in neurointerventional specialty (version 1) [D]. Chin J Cerebrovasc Dis 2020; 17: 107-112
53 Powers WJ, Rabinstein AA, Ackerson T. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50 (12) e344-e418
54 Sharma D, Rasmussen M, Han R. et al. Anesthetic management of endovascular treatment of acute ischemic stroke during COVID-19 pandemic: consensus statement from Society for Neuroscience in Anesthesiology & Critical Care (SNACC): endorsed by Society of Vascular & Interventional Neurology (SVIN), Society of NeuroInterventional Surgery (SNIS), Neurocritical Care Society (NCS), European Society of Minimally Invasive Neurological Therapy (ESMINT) and American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) Cerebrovascular Section. J Neurosurg Anesthesiol 2020; 32 (03) 193-201
55 COVID-19: Statement Regarding the Management of Minimal, Mild and Moderate Head Injury. 2020. Available at: http://media.neurotrauma.nu/2020/03/SNC-statement-COVID-19.pdf. Accessed June 15, 2020
56 Carney N, Totten AM, O’Reilly C. et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery 2017; 80: 6-15
57 Korupolu R, Stampas A, Gibbons C, Hernandez Jimenez I, Skelton F, Verduzco-Gutierrez M. COVID-19: screening and triage challenges in people with disability due to Spinal Cord Injury. Spinal Cord Ser Cases 2020; 6 (01) 35
58 Dicks MA, Clements ND, Gibbons CR, Verduzco-Gutierrez M, Trbovich M. Atypical presentation of Covid-19 in persons with spinal cord injury. Spinal Cord Ser Cases 2020; 6 (01) 38
59 Rodríguez-Cola M, Jiménez-Velasco I, Gutiérrez-Henares F. et al. Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury. Spinal Cord Ser Cases 2020; 6 (01) 39
60 Stillman MD, Capron M, Alexander M, Di Giusto ML, Scivoletto G. COVID-19 and spinal cord injury and disease: results of an international survey. Spinal Cord Ser Cases 2020; 6 (01) 21
61 Basics guidance on management of spinal cord injury patients during coronavirus (COVID-19) pandemic. 2020. Available at: https://www.iscos.org.uk/uploads/CV-19/updated%20files%204%2024%2020/ENG_Basic_guidance_on_management.pdf. Accessed June 16, 2020
62 Craen A, Logan G, Ganti L. Novel coronavirus disease 2019 and subarachnoid hemorrhage: a case report. Cureus 2020; 12 (04) e7846
63 Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental?. New Microbes New Infect 2020; 35: 100669
64 COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARSCoV- 2 infection: an international cohort study. Lancet 2020. Doi: 10.1016/S0140-6736(20)31182-X
65 Vollono C, Rollo E, Romozzi M. et al. Focal status epilepticus as unique clinical feature of COVID-19: a case report. Seizure 2020; 78: 109-112
66 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223) 497-506
67 Kim JE, Heo JH, Kim HO. et al. Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 2017; 13 (03) 227-233
68 Sharma K, Tengsupakul S, Sanchez O, Phaltas R, Maertens P. Guillain-Barré syndrome with unilateral peripheral facial and bulbar palsy in a child: a case report. SAGE Open Med Case Rep 2019; 7: X19838750
69 Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol 2020; 19 (05) 383-384
70 Elavarasi A, Goyal V. Hydroxychloroquine and myasthenia gravis-can one take this risk?. Ann Indian Acad Neurol 2020; 23: 360-361
71 Varan O, Kucuk H, Tufan A. Myasthenia gravis due to hydroxychloroquine. Reumatismo 2015; 67 (03) 849
72 Klimek A. The myasthenic syndrome after chloroquine [in Polish]. Neurol Neurochir Pol 1999; 33 (04) 951-954
73 Myles PS, Maswime S. Mitigating the risks of surgery during the COVID-19 pandemic. Lancet 2020; 396 (10243) 2-3
74 Aminian A, Safari S, Razeghian-Jahromi A, Ghorbani M, Delaney CP. COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period. Ann Surg 2020; 272 (01) e27-e29
75 Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020; 18 (06) 1421-1424
76 Dolhnikoff M, Duarte-Neto AN, de Almeida Monteiro RA. et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J Thromb Haemost 2020; 18 (06) 1517-1519
77 Goyal P, Choi JJ, Pinheiro LC. et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020; 382 (24) 2372-2374
78 Klok FA, Kruip MJHA, van der Meer NJM. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 2020; 191: 148-150
79 Lodigiani C, Iapichino G, Carenzo L. et al. Humanitas COVID-19 Task Force. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res 2020; 191: 9-14
80 Poissy J, Goutay J, Caplan M, et al; Lille ICU Haemostasis COVID-19 group. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 2020. Doi:10.1161/CIRCULATIONAHA.120.047430
81 Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 2020; 18 (05) 1094-1099
82 Wang T, Chen R, Liu C. et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol 2020; 7 (05) e362-e363
83 World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. World Health Organization; 2020. Available at: https://apps.who.int/iris/handle/10665/330893. Accessed January 28, 2020
84 Dogra S, Jain R, Cao M, et al. Hemorrhagic stroke and anticoagulation in COVID-19. J Stroke Cerebrovasc Dis 2020. Doi:10.1016/j.jstrokecerebrovasdis.2020.104984
85 Barazzoni R, Bischoff SC, Breda J. et al. endorsed by the ESPEN Council. ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection. Clin Nutr 2020; 39 (06) 1631-1638
86 Saez de la Fuente I, Saez de la Fuente J, Quintana Estelles MD. et al. Enteral nutrition in patients receiving mechanical ventilation in a prone position. J Parenter Enteral Nutr 2016; 40 (02) 250-255
87 National Tracheostomy Safety Project. Considerations for tracheostomy in the COVID-19 outbreak. 2020. Available at: https://icmanaesthesiacovid-19.org/considerations-for-tracheostomy-in-the-covid-19-outbreak. Accessed June 13, 2020
88 Shiba T, Ghazizadeh S, Chhetri D, St John M, Long J. Tracheostomy considerations during the COVID-19 pandemic. OTO Open 2020; 4 (02) X20922528
89 MacLaren G, Fisher D, Brodie D. Preparing for the most critically ill patients with COVID-19: the potential role of extracorporeal membrane oxygenation. JAMA 2020. Doi: 10.1001/jama.2020.2342
90 Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. JAMA 2019; 321 (12) 1200-1210
91 Edelson DP, Sasson C, Chan PS. et al. American Heart Association ECC Interim COVID Guidance Authors. Interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed COVID-19: from the Emergency Cardiovascular Care Committee and Get With The Guidelines-Resuscitation Adult and Pediatric Task Forces of the American Heart Association. Circulation 2020; 141 (25) e933-e943